Psychiatry · Worcester, MA
NPI
1487754974
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Behavioral Healthcare Services, 435 Shrewsbury Street
Worcester, MA, 01604
Phone (508) 753-5554
Groups this clinician bills Medicare through
Medicare paid, 2024
$416K
2,863 services
Medicare patients, 2024
367
Average age 58
Drug cost, 2024
$2.3M
16,799 prescriptions
Company payments, 2025
$85K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamad A Bahnassi was code 99214 (office e&m - established), 1,743 times for 356 patients. In total Mohamad A Bahnassi billed 2,863 services in 12 codes, and Medicare paid $416K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,743 | 356 | $75.90 | $132K |
| G2083 Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 255 | 12 | $865.74 | $221K |
| 99215 Office E&M - Established | Office | 144 | 11 | $121.40 | $17K |
| 99443 Telephone Services | Office | 41 | 40 | $89.42 | $3,666 |
By year: 2022 $298K for 3,429 services; 2023 $373K for 3,859 services; 2024 $416K for 2,863 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamad A Bahnassi prescribed most often to Medicare patients was Clonazepam, with 1,270 prescriptions and refills. In total Mohamad A Bahnassi wrote 16,799 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 1,270 | 1,400 | 144 | $11K |
| Trazodone Hcl Generic | 979 | 1,441 | 168 | $15K |
| Duloxetine Hcl Generic | 798 | 1,204 | 104 | $18K |
| Quetiapine Fumarate Generic | 766 | 1,211 | 97 | $20K |
| Gabapentin Generic | 687 | 779 | 83 | $16K |
| Bupropion Xl Bupropion Hcl | 651 | 974 | 83 | $12K |
| Zolpidem Tartrate Generic | 613 | 721 | 90 | $4,408 |
| Escitalopram Oxalate Generic | 610 | 865 | 94 | $6,508 |
| Lorazepam Generic | 584 | 607 | 71 | $5,650 |
| Sertraline Hcl Generic | 504 | 719 | 78 | $7,216 |
| Mirtazapine Generic | 480 | 664 | 73 | $6,850 |
| Risperidone Generic | 477 | 609 | 54 | $9,599 |
| Olanzapine Generic | 454 | 663 | 65 | $13K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 436 | 690 | 56 | $10K |
| Spravato Esketamine Hcl | 431 | 431 | 20 | $500K |
Brand drugs: 925 claims; generic drugs: 15,874 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamad A Bahnassi $85K ($85K in general payments such as food, travel and fees) from 16 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 137 | $25K |
| Alkermes, Inc. ALKS | 46 | $17K |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $15K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 60 | $13K |
| Janssen Pharmaceuticals, Inc JNJ | 30 | $7,961 |
| Abbvie Inc. ABBV | 42 | $5,078 |
| Vanda Pharmaceuticals Inc. VNDA | 38 | $521 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $225 |
| Lundbeck LLC | 13 | $219 |
| Supernus Pharmaceuticals, Inc. SUPN | 13 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.